We are independent & ad-supported. We may earn a commission for purchases made through our links.
Advertiser Disclosure
Our website is an independent, advertising-supported platform. We provide our content free of charge to our readers, and to keep it that way, we rely on revenue generated through advertisements and affiliate partnerships. This means that when you click on certain links on our site and make a purchase, we may earn a commission. Learn more.
How We Make Money
We sustain our operations through affiliate commissions and advertising. If you click on an affiliate link and make a purchase, we may receive a commission from the merchant at no additional cost to you. We also display advertisements on our website, which help generate revenue to support our work and keep our content free for readers. Our editorial team operates independently of our advertising and affiliate partnerships to ensure that our content remains unbiased and focused on providing you with the best information and recommendations based on thorough research and honest evaluations. To remain transparent, we’ve provided a list of our current affiliate partners here.

What is Glioblastoma?

Mary McMahon
By
Updated Mar 03, 2024
Our promise to you
The Health Board is dedicated to creating trustworthy, high-quality content that always prioritizes transparency, integrity, and inclusivity above all else. Our ensure that our content creation and review process includes rigorous fact-checking, evidence-based, and continual updates to ensure accuracy and reliability.

Our Promise to you

Founded in 2002, our company has been a trusted resource for readers seeking informative and engaging content. Our dedication to quality remains unwavering—and will never change. We follow a strict editorial policy, ensuring that our content is authored by highly qualified professionals and edited by subject matter experts. This guarantees that everything we publish is objective, accurate, and trustworthy.

Over the years, we've refined our approach to cover a wide range of topics, providing readers with reliable and practical advice to enhance their knowledge and skills. That's why millions of readers turn to us each year. Join us in celebrating the joy of learning, guided by standards you can trust.

Editorial Standards

At The Health Board, we are committed to creating content that you can trust. Our editorial process is designed to ensure that every piece of content we publish is accurate, reliable, and informative.

Our team of experienced writers and editors follows a strict set of guidelines to ensure the highest quality content. We conduct thorough research, fact-check all information, and rely on credible sources to back up our claims. Our content is reviewed by subject-matter experts to ensure accuracy and clarity.

We believe in transparency and maintain editorial independence from our advertisers. Our team does not receive direct compensation from advertisers, allowing us to create unbiased content that prioritizes your interests.

A glioblastoma is a malignant brain tumor which is usually fatal, with treatment for this cancer focusing on palliative care rather than attempting to cure the patient. This cancer is a type of astrocytoma, meaning that it arises in cells in the brain known as astrocytes, and it is the most common form of brain tumor. Fortunately, brain tumors in general are very rare, with around two percent of cancers occurring in the brain.

Like other astrocytomas, a glioblastoma begins to form when the genetic information in cells in the brain becomes damaged, causing cells to multiply out of control. In the case of a glioblastoma, the growth consists of an area of necrosis surrounded by poorly differentiated astrocytes. The patient can experience symptoms such as dizziness, nausea, confusion, difficulty balancing, vision problems, and other neurological issues as the tumor grows.

Doctors can diagnose a glioblastoma by using a medical imaging study to look at the brain, and biopsying the growth to find out what it is. When a pathologist examines the biopsy specimen, he or she can determine which kinds of cells are involved, and how aggressive the cancer appears to be. Glioblastomas are also known as Grade IV astrocytomas, referencing the type of cells in which the cancer originates, and the fact that these tumors are very aggressive.

A glioblastoma will not usually metastasize to other areas of the body, making management for the tumor primarily focused on keeping it from growing, and keeping the patient comfortable. Surgery may be recommended to remove as much of the tumor as possible, and chemotherapy and radiation can extend the patient's life, and make him or her more comfortable. New treatments are constantly being developed for conditions like glioblastoma, improving the prognosis and extending lifespan.

Men are most likely to develop this cancer, and it usually occurs in people over 50. There appear to be some genetic components to this cancer, and it may also be linked with environmental exposure to radiation. When diagnosed with a glioblastoma, patients should ask their doctors for honest opinions about the prognosis, and they may want to talk about end of life care so that they can make decisions about their care while they are still highly functional. It is also critical to talk to loved ones about specific wishes for care and treatment, and patients may want to consider creating a healthcare proxy, someone who will make sure that their wishes are carried out in the event that they are unable to communicate.

The Health Board is dedicated to providing accurate and trustworthy information. We carefully select reputable sources and employ a rigorous fact-checking process to maintain the highest standards. To learn more about our commitment to accuracy, read our editorial process.
Mary McMahon
By Mary McMahon

Ever since she began contributing to the site several years ago, Mary has embraced the exciting challenge of being a The Health Board researcher and writer. Mary has a liberal arts degree from Goddard College and spends her free time reading, cooking, and exploring the great outdoors.

Discussion Comments
By sunnySkys — On Feb 19, 2012

@KaBoom - That's always a concern with terminal illnesses. At what point do you stop invasive treatments and let the illness take its course? I think the article makes a good recommendation when it suggest patients discuss this with their loved ones when they are first diagnosed, rather than waiting until they are extremely sick.

It also sounds like hospice care could help in the case of someone who has a glioblastoma brain tumor. Hospice care focuses on making patients comfortable rather than on curing their disease.

By KaBoom — On Feb 18, 2012

I'm slightly relieved that only 2% of cancers occur in the brain. If you watch medical shows on television, you would think that brain tumors occur as frequently as the common cold!

This must mean that glioblastoma brain cancer isn't very common at all, because it's just one kind of brain cancer. Still, it sounds like one of the most aggressive types of cancers since it isn't very treatable. I think in cases like this, patients have to balance how much the treatment is going to extend their life versus what their quality of life will be like after they undergo treatment.

Mary McMahon
Mary McMahon

Ever since she began contributing to the site several years ago, Mary has embraced the exciting challenge of being a...

Learn more
The Health Board, in your inbox

Our latest articles, guides, and more, delivered daily.

The Health Board, in your inbox

Our latest articles, guides, and more, delivered daily.